Alan Meds Pricing: Medication, Membership, and Monthly Cost Breakdown

Last reviewed: September 8, 2026 Last updated: September 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Alan Meds' compounded semaglutide injection pricing presents two conflicting structures on official pages captured September 4, 2026. The primary medication page advertises a buy-one-get-one promotional offer: $315 upfront for two months of medication ($157.50 effective monthly rate, prepaid). A separate official article describes $297 for the first month, then $397 monthly ongoing. Both pages carry the same capture date; the conflict is real, and readers should confirm current pricing at checkout.

Alan Meds charges $0 monthly membership fee. Medication cost is the only recurring charge. Consultation, medication, and shipping are included in the quoted prices.

Over 12 months, if the promotional offer applied continuously (unverified assumption), total cost would be $1,890 ($157.50/month average—our calculation). Under the first-month/$397 ongoing structure, 12-month cost totals $4,664 ($388.67/month average—our calculation). PlexusDx compounded semaglutide injection runs $189/month month-to-month, $169/month on a three-month commitment, or $149/month on a six-month commitment—consistent pricing with no membership fee or promotional games.

Alan Meds pricing at a glance

Data captured September 4, 2026 from Alan Meds official pages.

Medication pricing: the promotional vs. standard conflict

Alan Meds' primary compounded semaglutide product page advertises a buy-one-get-one promotional offer: pay $315 upfront, receive two months of medication. That works out to $157.50 per month on a prepaid basis (our calculation). The offer includes consultation, medication, and shipping.

A separate official Alan Meds article—published on the tirzepatide supply update page but addressing semaglutide pricing—states $297 for the first month, then $397 monthly thereafter. Both pages were captured on the same date (September 4, 2026). We do not know which structure currently applies at checkout, whether the promotional offer renews beyond the initial purchase, or whether one has superseded the other. The conflict exists in Alan Meds' published materials, and prospective patients should confirm live pricing before purchase.

Alan Meds also lists compounded tirzepatide injection and oral semaglutide as available medications, but no checkout prices are published; an intake submission is required to see tirzepatide cost. This analysis focuses on the injectable semaglutide pricing for which we have conflicting documented evidence.

Membership and service fees

Alan Meds charges $0 monthly membership fee. The medication cost is the total recurring charge. Consultation, medication compounding, and shipping are included in the quoted medication price under both pricing structures.

Total monthly cost: scenario modeling

Because Alan Meds presents conflicting pricing structures, we calculate 12-month costs under three scenarios and compare them to PlexusDx.

Scenario A: Promotional offer applies continuously

If the $315 two-month promotional cycle were available and renewable for the full year (an unverified assumption):

• 6 two-month cycles × $315 = $1,890 total over 12 months
• $157.50 effective monthly rate (our calculation, prepaid basis)

No evidence confirms the promotional offer renews beyond the first purchase.

Scenario B: First-month discount, then standard $397 ongoing

Using the alternate official pricing structure:

• Month 1: $297 (first-month introductory rate)
• Months 2–12: 11 × $397 = $4,367
• Total: $4,664 over 12 months
• $388.67 average monthly cost (our calculation)

Scenario C: One promotional cycle, then standard $397

If the promotional offer applies once, then reverts to the $397 monthly rate:

• Months 1–2: $315 (promotional prepaid)
• Months 3–12: 10 × $397 = $3,970
• Total: $4,285 over 12 months
• $357.08 average monthly cost (our calculation)

PlexusDx semaglutide injection: transparent pricing

PlexusDx offers compounded semaglutide injection at three commitment levels, all month-to-month post-commitment with no membership fee:

PlexusDx pricing includes licensed provider consultation, compounded medication, shipping, and clinical monitoring. No membership fee, no hidden charges, no promotional introductory rates that revert to higher refill pricing.

Decision factors

Alan Meds strengths

Potentially lower introductory cost (if promotional offer applies and renews). The advertised $315 two-month promotional rate, if available and renewable, yields an effective $157.50 monthly cost—lower than any PlexusDx semaglutide option over the same prepaid period. However, no evidence confirms the offer renews, and a conflicting pricing structure appears on another official page captured the same day.

No membership fee. Alan Meds charges $0 for membership; medication cost is the only recurring expense. PlexusDx operates the same way—no membership fee, medication-only pricing.

Alan Meds gaps and uncertainties

Conflicting official pricing with no clarity on which applies. Two pricing structures—promotional $315/two months and first-month $297/ongoing $397—appear on Alan Meds official pages captured simultaneously. Prospective patients cannot determine from published materials which structure is live at checkout, whether the promotional offer is one-time or renewable, or what the true refill cost will be after any introductory period ends.

Significant cost difference between promotional and standard rates. If the promotional offer does not renew and the standard $397 monthly rate applies after the first cycle, 12-month costs rise sharply. Under the first-month/$397 scenario, Alan Meds' year-one cost ($4,664—our calculation) is more than double PlexusDx's month-to-month rate ($2,268—our calculation) and nearly triple the six-month commitment rate ($1,788—our calculation).

No published tirzepatide pricing. Alan Meds lists compounded tirzepatide as available but does not publish a checkout price; patients must complete an intake to see cost. This limits comparison for patients considering tirzepatide over semaglutide.

No documented cancellation or refund policy. Our evidence capture found no published terms on pausing, canceling, or obtaining refunds for prepaid medication.

Choose Alan Meds if…

You're willing to accept pricing uncertainty in exchange for a potentially lower introductory rate, you can confirm at checkout that the promotional offer applies and understand the refill cost before committing, and you plan to use compounded semaglutide injection without need for tirzepatide pricing transparency. Alan Meds may offer a short-term cost advantage if the promotional structure is live and renewable, but the conflicting evidence and lack of published refill clarity make long-term cost planning difficult.

Choose PlexusDx if…

You want transparent, consistent pricing with no promotional introductory rates that revert to higher refills, a documented range of commitment options (month-to-month at $189, three-month at $169, six-month at $149), and published pricing for both semaglutide and tirzepatide (injection and oral) so you can compare options before intake. PlexusDx pricing includes consultation, medication, shipping, and monitoring, with no membership fee and no surprise refill increases. Over 12 months, even PlexusDx's month-to-month semaglutide rate ($2,268 total—our calculation) costs less than Alan Meds' first-month/$397 ongoing structure ($4,664—our calculation), and the six-month commitment ($1,788—our calculation) approaches the promotional rate Alan Meds advertises but does not confirm as renewable.

Methodology and freshness

Alan Meds pricing data was captured September 4, 2026 from the official compounded semaglutide product page (promotional offer) and an official tirzepatide supply update article (first-month/$397 structure). Both sources are Alan Meds-published pages; the conflict is present in the provider's own materials. No payment was submitted; verification stopped before checkout. Tirzepatide pricing is marked as unavailable because no published figure exists outside the intake-gated checkout flow.

PlexusDx pricing is current as of September 8, 2026 and reflects live product-page rates. All 12-month cost calculations and effective monthly rates derived from promotional or prepaid structures are our calculations, labeled as such throughout. We present both Alan Meds pricing structures without smoothing the conflict; readers are advised to confirm current pricing, renewal terms, and refill costs directly with Alan Meds before purchase.

Frequently Asked Questions

Does Alan Meds charge a membership fee?

No. Alan Meds charges $0 monthly membership fee. The medication cost is the only recurring charge, and it includes consultation, compounded medication, and shipping under both documented pricing structures.

Which Alan Meds pricing structure is currently active?

As of September 4, 2026, Alan Meds published two conflicting pricing structures on official pages: a promotional $315 two-month offer and a first-month $297/ongoing $397 monthly structure. We do not know which applies at checkout or whether the promotional offer renews. Confirm live pricing before purchase.

How does Alan Meds' promotional rate compare to PlexusDx over 12 months?

If Alan Meds' promotional $315 two-month cycle renewed for a full year (unverified), the total would be $1,890 ($157.50/month—our calculation). PlexusDx six-month commitment costs $1,788 over 12 months ($149/month—our calculation). If the Alan Meds promo does not renew and the $397 rate applies, 12-month cost rises to $4,285 or $4,664 depending on structure—significantly higher than any PlexusDx option.

Can I see Alan Meds tirzepatide pricing before starting an intake?

No. Alan Meds does not publish tirzepatide checkout pricing on its website. You must complete an intake to see the cost. PlexusDx publishes tirzepatide injection pricing on its product pages: $289/month month-to-month, $269/month three-month commitment, $249/month six-month commitment.

What if I need to cancel or get a refund with Alan Meds?

Our evidence capture found no published cancellation or refund policy on Alan Meds' official pages as of September 4, 2026. Contact Alan Meds directly to confirm terms before committing, especially if prepaying for the two-month promotional offer.

Sources

• Alan Meds official compounded semaglutide product page, https://www.alanmeds.com/medications/personalized-compounded-semaglutide, accessed September 4, 2026
• Alan Meds tirzepatide supply update article (containing semaglutide pricing), https://www.alanmeds.com/resource/tirzepatide-supply-update, accessed September 4, 2026
• PlexusDx semaglutide injection product page, https://plexusdx.com/products/semaglutide-injection, accessed September 8, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.